Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Losartan Market Size Changed, over the years?

The increasing size of the losartan market has been consistent in the last few years. It is projected to expand from a value of $1.44 billion in 2024 to $1.50 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 4.6%. This progress in the past era can be linked to a rising elderly populace, augmented healthcare spending, proliferating cases of diabetic nephropathy, enhanced consciousness about managing blood pressure, and an increased uptake of generic ARBs.

How Much Will the Losartan Market Be Worth in 2029?

We are likely to witness a constant expansion in the losartan market in the upcoming years, with it being projected to hit $1.79 billion by 2029 due to a compound annual growth rate (CAGR) of 4.6%. The increasing preference for affordable antihypertensive medications, combined with a focus on preventive healthcare, the surge in lifestyle-related health conditions, better access to healthcare services in emerging markets, and the constant introduction of generic versions, are all contributing factors for the broadening market in the forecast period. The projected phase will also see trends like advancements in drug delivery systems, the introduction of fixed-dose blend therapies, innovative formulation technologies, improved manufacturing practices, and the progression of personalized medicine approaches.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Which is the Largest Company in the Losartan Market?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

What Are the Main Market Drivers in the Losartan Industry?

The rise in hypertension cases is anticipated to stimulate the expansion of the losartan market. Hypertension, characterised by continuously elevated blood pressure, can enhance the risk of heart diseases, strokes, and other serious health issues. The increasing prevalence of hypertension is associated with high-salt and processed food diets that result in fluid build-up and augmented heart strain. Losartan aids in managing hypertension by obstructing angiotensin II, a hormone that constricts blood vessels. This action allows the vessels to relax and expand, reducing blood pressure and lessening the heart’s burden. For example, the American Heart Association, a nonprofit organization based in the US, reported in January 2024 that the primary cause of 131,454 deaths in 2022 was high blood pressure, which was an increase from the 124,508 deaths in 2021. Consequently, the escalating prevalence of hypertension is fuelling the growth of the losartan market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

How Is the Losartan Market Segments Structured?

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

What Strategic Trends Are Transforming the Losartan Market?

Leading organizations in the losartan market are concentrating their efforts on generating innovative products and achieving approvals, such as losartan potassium oral suspension. This is in a bid to improve patient adherence and widen therapeutic uses. Losartan potassium oral suspension is a liquid version of losartan potassium medication, designed for those who find it difficult to consume tablets. For instance, in March 2025, Food and Drug Administration (FDA) approval was granted to Scienture Holdings Inc., a biopharmaceutical firm based in the US, for Arbli. This product is a ready-to-use liquid formulation for tackling hypertension, reducing stroke risk in hypertensive patients with left ventricular hypertrophy, and managing diabetic nephropathy in patients with type 2 diabetes. The formulation allows for exact dosing without compounding and comes in a 165 mL peppermint-flavored suspension (10 mg/mL) that has an 18-month shelf life when stored at room temperature.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Which Global Regions Offer the Highest Growth in the Losartan Market?

North America was the largest region in the losartan market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24284&type=smp

This Report Delivers Insight On:

1. How big is the losartan market, and how is it changing globally?

2. Who are the major companies in the losartan market, and how are they performing?

3. What are the key opportunities and risks in the losartan market right now?

4. Which products or customer segments are growing the most in the losartan market?

5. What factors are helping or slowing down the growth of the losartan market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model